SEC Form 4 · accession 0001193125-26-272703
Aura Biosciences, Inc. · AURA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony S Gibney
Officer — See Remarks
Period of report
Jun 16, 2026
Accepted (ET)
Jun 16, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001501796
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 16, 2026 | S | 12,824 | $6.42 | D | 265,354 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
Remarks
Chief Financial and Business Officer.